Seeking Alpha

Seeking Alpha Portfolio App for iPad

69 people get SHP articles and Market Currents by email alert.

Get email alerts on SHP »

SHP

ShangPharma Corporation

5/18/2013, 9:40 PM ET

Quote & Headlines Market Currents StockTalk

shp chart

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

69 people get SHP articles and Market Currents by email alert.

Get email alerts on SHP »

HEADLINES:

ALL | PRO | FOCUS | RELATED | TRANSCRIPTS | NEWS & PR

ShangPharma Corporation Announces Completion of Merger

PR Newswire (Mar 28, 2013)
ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement

PR Newswire (Mar 20, 2013)
ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders

PR Newswire (Feb 25, 2013)
Age-Related Macular Degeneration: A Promising Investment Opportunity
Cris Frangold • Mon, Jan 21 • 4 Comments
Despite Political Obstacles, Healthcare Multinationals Flock To China
Stock Traders Daily • Thu, Dec 27, 2012 • 1 Comment
China Biotech In Review: WuXi PharmaTech, PRA Form Clinical CRO JV
ChinaBio Today • Sun, Dec 23, 2012
ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction

PR Newswire (Dec 21, 2012)
ShangPharma Announces Third Quarter 2012 Results

PR Newswire (Nov 20, 2012)
ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012

PR Newswire (Nov 6, 2012)
ShangPharma and Harbour Antibodies Announce Licensing Agreement

PR Newswire (Sep 13, 2012)
4 Cash-Heavy Biotech Stocks That Analysts Rate As Strong Buy
ZetaKap • Tue, Aug 21, 2012 • 1 Comment
ShangPharma Announces Second Quarter 2012 Results

PR Newswire (Aug 20, 2012)
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012

PR Newswire (Aug 6, 2012)
ShangPharma Independent Committee Appoints Financial Advisor

PR Newswire (Aug 3, 2012)
ShangPharma Independent Committee Appoints Chairman and Legal Counsel

PR Newswire (Jul 17, 2012)
5 Cash-Heavy Biotechs That Analysts Favor
ZetaKap • Sun, Jul 15, 2012 • 3 Comments
ShangPharma Going Private
Markus Aarnio • Mon, Jul 9, 2012
ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS

PR Newswire (Jul 6, 2012)
4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week Lows
ZetaKap • Thu, Jun 14, 2012
China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
ChinaBio Today • Sun, Jun 10, 2012

To learn more about Seeking Alpha Pro, click here.

ShangPharma Going Private
Markus Aarnio • Mon, Jul 9, 2012
ShangPharma Reports 26% Increase in Q1 Revenues
ChinaBio Today • Sun, May 22, 2011
ShangPharma's New Manufacturing Facility to Support Clients Through Phase III Trials
ChinaBio Today • Sun, Jan 16, 2011 • 1 Comment
ShangPharma Prices IPO at $15, Plans to Broaden Services
ChinaBio Today • Wed, Oct 20, 2010

Age-Related Macular Degeneration: A Promising Investment Opportunity
Cris Frangold • Mon, Jan 21 • 4 Comments
Despite Political Obstacles, Healthcare Multinationals Flock To China
Stock Traders Daily • Thu, Dec 27, 2012 • 1 Comment
China Biotech In Review: WuXi PharmaTech, PRA Form Clinical CRO JV
ChinaBio Today • Sun, Dec 23, 2012
4 Cash-Heavy Biotech Stocks That Analysts Rate As Strong Buy
ZetaKap • Tue, Aug 21, 2012 • 1 Comment
5 Cash-Heavy Biotechs That Analysts Favor
ZetaKap • Sun, Jul 15, 2012 • 3 Comments
4 Cash Heavy Small Cap Biotech Stocks Trading Near 52-Week Lows
ZetaKap • Thu, Jun 14, 2012
China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
ChinaBio Today • Sun, Jun 10, 2012
3 Undervalued BRIC Stocks With Strong Hedge Fund Buying
Kapitall • Tue, May 8, 2012
PWC Zhong Tian: A Chinese Auditor With A Flawless Record
Adam Gefvert • Fri, Mar 30, 2012 • 87 Comments
The Week In Review: Are WuXi PharmaTech And ShangPharma Takeover Targets?
ChinaBio Today • Sun, Feb 5, 2012
Are WuXi PharmaTech and ShangPharma M&A Targets?
ChinaBio Today • Thu, Feb 2, 2012
20 Biotech Stocks That Hedge Funds Are Selling
Kapitall • Sun, Dec 11, 2011 • 1 Comment
Equal Energy: An Unparalleled Opportunity
Nawar Alsaadi • Wed, Nov 2, 2011 • 24 Comments
China Biotech Week In Review: BioBay Park Forms Partnership With Roche, Harvard
ChinaBio Today • Sun, Oct 30, 2011
China Biotech Week In Review: Avenue Capital Starts $313 Million Fund For China Medical City
ChinaBio Today • Mon, Sep 19, 2011
China Biotech Q1 Earnings Review: Healthy Revenue Increases, Smaller Profit Growth
ChinaBio Today • Tue, May 24, 2011 • 1 Comment
China Biotech in Review: U.S. Charges 4 China API Makers With Price-Fixing
ChinaBio Today • Mon, Mar 21, 2011 • 3 Comments
JPMorgan's Extremely Bullish New Stock Picks
Insider Monkey • Mon, Mar 21, 2011 • 7 Comments
2010 Year-End U.S. IPO Review and 2011 Outlook
Trent Tillman • Fri, Mar 4, 2011 • 3 Comments
China Biotech Week in Review: Shanghai Pharma Active in Drug Distribution Rollup
ChinaBio Today • Sun, Jan 16, 2011 • 1 Comment

There are no Transcripts on SHP.

London Markets: U.K. stocks end higher after ECB rate cut

at MarketWatch.com (May 2, 2013)
Europe Markets: European stocks edge up as ECB cuts rates

at MarketWatch.com (May 2, 2013)
ShangPharma Corporation Announces Completion of Merger

PR Newswire (Mar 28, 2013)
ShangPharma Corporation Announces Shareholders' Approval of Merger Agreement

PR Newswire (Mar 20, 2013)
London Markets: FTSE 100 rises for second day; RBS drops

at MarketWatch.com (Feb 28, 2013)
ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders

PR Newswire (Feb 25, 2013)
London Markets: Vodafone shares weigh on FTSE 100 index

at MarketWatch.com (Feb 14, 2013)
London Markets: FTSE 100 jumps to highest since May 2008

at MarketWatch.com (Jan 9, 2013)
ShangPharma Corporation Enters into Definitive Merger Agreement for Going Private Transaction

PR Newswire (Dec 21, 2012)
ShangPharma Announces Third Quarter 2012 Results

PR Newswire (Nov 20, 2012)
ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012

PR Newswire (Nov 6, 2012)
ShangPharma and Harbour Antibodies Announce Licensing Agreement

PR Newswire (Sep 13, 2012)
Health Care Sector Wrap

at Fox Business (Aug 28, 2012)
ShangPharma Announces Second Quarter 2012 Results

PR Newswire (Aug 20, 2012)
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012

PR Newswire (Aug 6, 2012)
ShangPharma Independent Committee Appoints Financial Advisor

PR Newswire (Aug 3, 2012)
ShangPharma Independent Committee Appoints Chairman and Legal Counsel

PR Newswire (Jul 17, 2012)
Movers & Shakers: Friday’s biggest gaining and declining stocks

at MarketWatch.com (Jul 6, 2012)
ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS

PR Newswire (Jul 6, 2012)
London Markets: U.K. stocks drop for fourth day, banks off

at MarketWatch.com (Jun 26, 2012)

SHP vs. ETF Alternatives

Company Description

Currently, there's no company description for SHP.

Sector: Healthcare

Industry: Biotechnology

Country: China

All
| Earnings
| Dividends
| M&A
| On the move

Friday, December 21, 2012, 9:10 AM Premarket gainers: HALO +19%. CEMI +17%. ASCA +17%. APPY +14%. RHT +5%. PNK +5%. SHP +5%.
Losers: ECTE -18%. RIMM -14%. ALU -7%. 1 Comment [On the Move]
Tuesday, November 20, 2012, 6:18 AM ShangPharma (SHP): Q3 EPS of $0.15 misses by $0.05. Revenue of $31.9M (+10.6% Y/Y) misses by $2.1M. (PR) Comment! [Earnings, Healthcare]
Monday, August 20, 2012, 12:23 PM ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report. Comment! [Earnings, Global & FX, Healthcare, On the Move]
Monday, August 20, 2012, 7:44 AM ShangPharma (SHP): Q2 EPS of $0.11 misses by $0.09. Revenue of $31.8M (+15.7% Y/Y) misses by $1M. (PR) Comment! [Earnings, Healthcare]
Friday, July 6, 2012, 8:11 AM Shares of ShangPharma (SHP) move up 15.1% premarket after the firm receives a "going private" buyout offer from a group of private investors at $8.50-$9.50 per ADS. The company says that it's forming a special committee to study the offer. Comment! [M&A, Healthcare]
Friday, August 12, 2011, 11:02 AM Chinese biotech research firm ShangPharma (SHP +18.3%) pops after announcing a $10M stock repurchase program. In addition, founder and CEO Michael Xin Hui intends to purchase up to $1M worth of its shares through a personal, family-owned company. Comment! [Healthcare, Global & FX, On the Move]